Literature DB >> 86990

Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies.

W G Laver, W Gerhard, R G Webster, M E Frankel, G M Air.   

Abstract

Variants of A/PR/8/34 (HON1) influenza virus, having hemagglutinin molecules with probably a single altered antigenic determinant, were isolated by growing the virus in the presence of the monoclonal hybridoma antibody PEG-1. The variants were analyzed by peptide mapping and characterized antigenically by using PEG-1 and four other monoclonal hybridoma antibodies to PR8 hemagglutinin. Peptide maps of the large hemagglutinin polypeptide, HA1, from 8 out of 10 variants showed a single changed peptide. This peptide from two of the variants was analyzed, and in each case a serine residue in the wild-type hemagglutinin was replaced by leucine in the variant. Although these eight variants showed identical peptide maps, one could be discriminated antigenically from the others with one of the hybridomas. (The peptide maps represented about one-third of the HA1 molecule.) Of the other two variants, one gave the same HA1 map as the wild type, but could be distinguished antigenically from wild-type virus by two of the hybridomas. The other was unique, and could be distinguished, both antigenically and by peptide mapping, from the other variants. Since a large number of the variants selected with PEG-1 showed the same peptide change, it is likely that this alteration in amino acid sequence (serine to leucine) was responsible for the inability of the variants to bind PEG-1 monoclonal antibody. We do not know, however, whether the changed amino acids were located within the antigenic sites or whether the change occurred somewhere else in the hemagglutinin molecule and altered the determinants through conformational changes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86990      PMCID: PMC383264          DOI: 10.1073/pnas.76.3.1425

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains.

Authors:  W G Laver; J C Downie; R G Webster
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

2.  Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

3.  Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.

Authors:  S Udenfriend; S Stein; P Böhlen; W Dairman; W Leimgruber; M Weigele
Journal:  Science       Date:  1972-11-24       Impact factor: 47.728

4.  Selection of antigenic mutants of influenza viruses. Isolation and peptide mapping of their hemagglutination proteins.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1968-02       Impact factor: 3.616

5.  Production of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells.

Authors:  H Koprowski; W Gerhard; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

7.  Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.

Authors:  I ARCHETTI; F L HORSFALL
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

8.  Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine.

Authors:  D HAMRE; C G LOOSLI; P GERBER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

9.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

10.  Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.

Authors:  W Gerhard; R G Webster
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

2.  Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein.

Authors:  Ruth V Bushnell; John K Tobin; Jinxue Long; Stacey Schultz-Cherry; A Ray Chaudhuri; Peter L Nara; Gregory J Tobin
Journal:  Virol J       Date:  2010-08-24       Impact factor: 4.099

3.  Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases.

Authors:  G Spira; R R Pollock; A Bargellesi; M D Scharff
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

4.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  The new influenza A H1N1 virus: balancing on the interface of humans and animals.

Authors:  Frank J U M van der Meer; Karin Orsel; Herman W Barkema
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

6.  Avian influenza from an ecohealth perspective.

Authors:  Les Simms; Martyn Jeggo
Journal:  Ecohealth       Date:  2014-04-24       Impact factor: 3.184

7.  Immunogenicity of low-pH treated whole viral influenza vaccine.

Authors:  Fu-Shi Quan; Zhu-Nan Li; Min-Chul Kim; Dan Yang; Richard W Compans; David A Steinhauer; Sang-Moo Kang
Journal:  Virology       Date:  2011-06-30       Impact factor: 3.616

8.  Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.

Authors:  E H Beachey; A Tartar; J M Seyer; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.

Authors:  A Natali; P F Panizzi; C Chezzi; J S Oxford
Journal:  J Hyg (Lond)       Date:  1984-04

10.  Genomic changes associated with antigenic variation of visna virus durig persistent infection.

Authors:  J E Clements; F S Pedersen; O Narayan; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.